Skip to main content
. 2019 Dec 10;10:1313. doi: 10.3389/fneur.2019.01313

Table 4.

Adverse events observed during whole observation period.

Adverse events Total n (%) Children n (%) Adults n (%)
At least one AE 25 (71.4) 16 (84.2) 9 (56.3)
Somnolence 14 (40) 11(57.9) 3 (18.8)
Diarrhea 12 (34.3) 7 (38.8) 5 (31.3)
Weight gain >5% 8 (22.9) 8 (42.1) 0 (0)
Loss of appetite 7 (20) 5 (26.3) 2 (12.5)
Irritability 7 (20) 6 (31.6) 1 (6.3)
Increased appetite 5 (14.3) 4 (21.1) 1 (6.3)
Weight loss >5% 4 (11.4) 2 (10.5) 2 (12.5)
Others* 4 (11.4) 4 (21.1) 0 (0)
*

drowsiness (n = 3), extrapyramidal symptoms (n = 1).

AE, adverse event.